(Q37959060)

25 August 2017

title

Role of C-reactive protein in cerebrovascular disease: a critical review (English)

1 reference

25 August 2017

main subject

cerebrovascular disease

1 reference

3

Daniel Agustin Godoy

1 reference

25 August 2017

2

Mitchell S V Elkind

1 reference

25 August 2017

Mario Di Napoli

1

1 reference

25 August 2017

Puneetpal Singh

series ordinal

4

1 reference

25 August 2017

Francesca Papa

series ordinal

5

1 reference

25 August 2017

Aurel Popa-Wagner

series ordinal

6

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Expert Review of Cardiovascular Therapy

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1565-1584

1 reference

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammation and cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Human C-reactive protein: expression, structure, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Pattern recognition by pentraxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The physiological structure of human C-reactive protein and its complex with phosphocholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Three dimensional structure of human C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Variations in binding characteristics of glycosylated human C-reactive proteins in different pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Induction of glycosylation in human C-reactive protein under different pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Structural recognition and functional activation of FcγR by innate pentraxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein isoforms differ in their effects on thrombus growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein does not opsonize early apoptotic human neutrophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The interaction of C-reactive protein and serum amyloid P component with nuclear antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Function of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Regulation of complement activation by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein: structural biology and host defense function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein upregulates complement-inhibitory factors in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Complement factor H binds to denatured rather than to native pentameric C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Lack of specific receptors for C-reactive protein on white blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein: risk marker or mediator in atherothrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Rat C-reactive protein activates the autologous complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Proinflammatory cytokines in CRP baseline regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Expression of C-reactive protein and heat-shock protein-70 in the lung epithelial cell line A549, in response to PM10 exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Relation of dietary fat and fiber to elevation of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Distribution and correlates of C-reactive protein concentrations among adult US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Association of C-reactive protein and metabolic syndrome in a rural Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Early origins of inflammation: microbial exposures in infancy predict lower levels of C-reactive protein in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Endogenous sex hormones and C-reactive protein in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Relation between markers of systemic vascular inflammation and smoking in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Socioeconomic position, health behaviors, and C-reactive protein: a moderated-mediation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

What does minor elevation of C-reactive protein signify?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein and coronary heart disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Allelic spectrum of the natural variation in CRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The TNF-α G-308A polymorphism is associated with C-reactive protein levels: The HERITAGE Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Genetic Polymorphisms and the Risk of Stroke After Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Association of common CRP gene variants with CRP levels and cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Relation of polymorphism within the C-reactive protein gene and plasma CRP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Association study between C-reactive protein genes and ischemic stroke in Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Impact of innate inflammation in population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Levels of acute phase proteins remain stable after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive-protein levels associated with infection predict short- and long-term outcome after supratentorial intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein induced expression of adhesion molecules in cultured cerebral microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammation as a therapeutic target in acute ischemic stroke treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Targeting C-reactive protein for the treatment of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Social interaction improves experimental stroke outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-reactive protein: structure affects function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Distributions of C-reactive Protein Measured by High-Sensitivity Assays in Apparently Healthy Men and Women from Different Populations in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

C-Reactive Protein and Cerebral Small-Vessel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

The binding site for C1q on IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.159

21 January 2018

Identifiers

DOI

10.1586/ERC.11.159

1 reference

25 August 2017

1 reference